Drug Information

Drug General Information
Drug ID
D09GLS
Former ID
DCL000412
Drug Name
GSK1614235
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 1 [523921]
Company
GSK
Target and Pathway
Target(s) Sodium/glucose cotransporter 1 Target Info Blocker [550963]
KEGG Pathway Carbohydrate digestion and absorption
Bile secretion
Mineral absorption
PathWhiz Pathway Lactose Degradation
Trehalose Degradation
Reactome Hexose transport
Na+-dependent glucose transporters
Inositol transporters
WikiPathways NRF2 pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
Metabolism of carbohydrates
References
Ref 523921ClinicalTrials.gov (NCT01607385) A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.. U.S. National Institutes of Health.
Ref 550963Clinical pipeline report, company report or official report of GlaxoSmithKline (2009).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.